Your browser doesn't support javascript.
loading
Thymidylate synthase gene polymorphism predicts disease free survival in stage II-III rectal adenocarcinoma patients receiving adjuvant 5-FU-based chemotherapy.
Su, Xiaona; Li, Songlin; Zhang, Hui; Xiao, He; Chen, Chuan; Wang, Ge.
Afiliação
  • Su X; Cancer Center, Institute of Surgery Research, Third Affiliated Hospital, Army Medical University (Third Military Medical University), Chongqing 400042, China.
  • Li S; Cancer Center, Institute of Surgery Research, Third Affiliated Hospital, Army Medical University (Third Military Medical University), Chongqing 400042, China.
  • Zhang H; Medbanks (Beijing) Network Technology Co, Ltd., Beijing 100000, China.
  • Xiao H; Cancer Center, Institute of Surgery Research, Third Affiliated Hospital, Army Medical University (Third Military Medical University), Chongqing 400042, China.
  • Chen C; Cancer Center, Institute of Surgery Research, Third Affiliated Hospital, Army Medical University (Third Military Medical University), Chongqing 400042, China.
  • Wang G; Cancer Center, Institute of Surgery Research, Third Affiliated Hospital, Army Medical University (Third Military Medical University), Chongqing 400042, China. wangge70@hotmail.com.
Chin Clin Oncol ; 8(3): 28, 2019 Jun.
Article em En | MEDLINE | ID: mdl-30823845
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Polimorfismo Genético / Neoplasias Retais / Timidilato Sintase / Adenocarcinoma / Fluoruracila Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Polimorfismo Genético / Neoplasias Retais / Timidilato Sintase / Adenocarcinoma / Fluoruracila Idioma: En Ano de publicação: 2019 Tipo de documento: Article